免疫介导性风湿病与健康成人肌肉力量比较:一项荟萃分析
该系统综述与荟萃分析纳入26项病例对照研究、共2661名以女性为主的免疫介导性风湿病患者,比较其与年龄性别匹配健康对照的肌肉力量。女性患者握力(MD -9.53 kg,95%CI -11.78至-7.28)及下肢肌力(MD -63.10 Nm,95%CI -94.18至-32.01)均低于健康对照,男性握力差异不显著;低肌力与较长病程、疾病活动度升高及躯体功能下降呈中度相关。
要点
- 女性免疫介导性风湿病患者握力和下肢肌力显著低于健康对照。
- 男性患者握力与健康对照无显著差异。
- 低肌力与较长病程、疾病活动度升高和躯体功能下降相关。
核心结论
- 免疫介导性风湿病患者肌肉力量低于健康对照,女性尤为明显。
- 低肌力与较长病程、疾病活动度恶化及躯体功能下降呈中度相关。
研究设计与样本
- 系统综述与病例对照研究的荟萃分析,检索Embase、MEDLINE、Web of Science和Cochrane数据库至2023年11月。
- 最终纳入26项研究、共2661名个体,以女性为主,比较免疫介导性风湿病患者与年龄性别匹配健康对照的肌肉力量。
主要发现
- 女性免疫介导性风湿病患者握力低于健康对照(MD -9.53 kg,95%CI -11.78至-7.28)。
- 男性免疫介导性风湿病患者握力与健康对照无显著差异。
- 女性免疫介导性风湿病患者下肢肌力低于健康对照(MD -63.10 Nm,95%CI -94.18至-32.01)。
- 类风湿关节炎中4项研究考察肌力与临床特征:1项与年龄和疾病活动度相关,2项与病程相关,3项与躯体功能相关。
- 系统性红斑狼疮中仅2项研究显示低肌力与年龄、疾病活动度和疲劳相关;脊柱关节炎和系统性硬化症中未发现相关。
临床怎么用
- 对免疫介导性风湿病患者应关注肌肉力量评估,女性患者尤需警惕握力和下肢肌力下降。
- 可将病程较长、疾病活动度升高及躯体功能下降的患者作为肌力减退的高危人群进行针对性干预。
局限性
- 纳入研究以女性为主,男性肌力结果解释受限。
- 关于肌力与临床特征关联的研究数量较少,部分疾病未发现关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Patients with immune-mediated rheumatic diseases (IMRDs) often exhibit reduced muscle strength. Therefore, this review aimed to evaluate muscle strength in patients with IMRDs compared with healthy control and to summarize the relationship between low muscle strength and clinical features in patients with IMRDs. DESIGN: Systematic review with meta-analysis of case-control studies. SETTING AND PARTICIPANTS: Patients with IMRDs. METHODS: A comprehensive search was conducted in the Embase, MEDLINE, Web of Science, and Cochrane databases to identify relevant studies published up to November 2023 on rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, and spondyloarthritis. Meta-analysis was performed using a random-effects model to determine the mean difference (MD) in muscle strength between patients with IMRDs and an age- and sex-matched healthy control group. RESULTS: We identified 11,692 studies, and 760 studies were selected for screening. Ultimately, 26 studies met the inclusion criteria, composed of 2661 individuals, mostly women. The IMRDs women group had lower handgrip muscle strength (MD, -9.53; 95% CI, -11.78 to -7.28 kg) than the healthy control group, whereas the handgrip strength men groups did not differ significantly from that of the healthy control group. Similar trend was observed in lower limb muscle strength for the IMRDs women group than the healthy control group (MD, -63.10; 95% CI, -94.18 to -32.01 Nm). Four studies examined muscle strength and clinical features in rheumatoid arthritis: one associated it with age and disease activity, 2 associated it with disease duration, and 3 associated it with physical function. In systemic lupus erythematosus, only 2 studies associated low muscle strength with age, disease activity, and fatigue. No associations were found in spondyloarthritis, and none were found in systemic sclerosis. CONCLUSIONS AND IMPLICATIONS: Patients with IMRD exhibit lower muscle strength than healthy counterparts, with low strength moderately associated with longer disease duration, worsening disease activity, and decline in physical function. Targeted interventions are crucial for preventing and managing muscle weakness in IMRDs.
引用
- Cavalheiro do Espírito Santo R, Peterson Dos Santos L, Melo G, et al. Muscle Strength Comparison in Immune-Mediated Rheumatic Disease vs Healthy Adults: A Meta-Analysis. J Am Med Dir Assoc. 2024. PMID: 39366668. doi:10.1016/j.jamda.2024.105293
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。